IMCD Inaugurates New Pharmaceutical and Food & Nutrition Hub in New Jersey

The IMCD Group, a leading global partner for the distribution and formulation of specialty chemicals and ingredients, opened a new hub designed for technical development and knowledge sharing in Allendale, New Jersey, USA. The inauguration took place on June 25. The new facilities are part of IMCD’s network of more than 80 technical centres globally.

The new facilities offer expanded laboratory capabilities for product innovation, along with a dedicated learning space for technical seminars, workshops, and collaborative learning. The local facilities will benefit from state-of-the-art technical capabilities, connected to experts across the Global lab network via the company’s digital analytics platform.

The hub features a dedicated Food & Nutrition Application Lab and Bakery Lab designed for the co-creation of trend-driven formulation solutions across bakery, beverage, confectionery, dairy, nutrition, and savory applications. From concept ideation and prototype development to formulation optimization, the centre empowers local customers to bring innovative concepts to life and accelerate speed to market with market-ready solutions.

The Pharmaceutical Technical Centre will support the development of patient-friendly solid, semi-solid and liquid formulations for pharmaceuticals and dietary supplements with state-of-the-art equipment and technologies. This includes regulatory advice, practical training and knowledge exchange in the global laboratory network.

Emilie Pharand, North America Food & Nutrition Vice-President at IMCD, stated “Our US Technical Hub is more than a laboratory; it represents an exciting milestone in our commitment to supporting our North American customers and partners. […]  We are excited to welcome customers and partners into this space to co-create what’s next.”

Sibu Varghese, IMCD Pharmaceuticals US Vice-President also added to the official statements “By combining IMCD’s global expertise with deep local insight, these new facilities will provide valuable technical resources to help North American customers accelerate product development across a broad range of dosage forms, supported by active pharmaceutical ingredients (API) and formulation expertise.”